Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 20,261 | 0 | 0 | 0 | 0 |
| Cost of Goods | 13,392 | N/A | N/A | N/A | N/A |
| Gross Profit | 6,870 | N/A | N/A | N/A | N/A |
| Operating Expenses | 8,055 | 33 | 27 | 23 | 31 |
| Operating Income | -794 | -33 | -27 | -23 | -31 |
| Interest Expense | 239 | 0 | 0 | 0 | 0 |
| Other Income | 90 | 0 | 29 | 0 | 0 |
| Pre-tax Income | -943 | -33 | 1 | -23 | -31 |
| Income Tax | -129 | -1 | -2 | 2 | 2 |
| Net Income Continuous | -814 | -32 | 3 | -25 | -33 |
| Net Income | $-814 | $-32 | $3 | $-25 | $-33 |
| EPS Basic Total Ops | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-628 | $-33 | $-27 | $-23 | $-31 |